Apimeds Pharmaceuticals US, Inc. (APUS)
1.390
-0.16
(-10.34%)
USD |
NYAM |
Feb 20, 16:00
1.36
-0.03
(-2.14%)
After-Hours: 20:00
Apimeds Pharmaceuticals US Total Liabilities (Quarterly) : 1.089M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
| Imunon, Inc. | 4.906M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.25M |
| Shareholders Equity (Quarterly) | 8.161M |
| Debt to Equity Ratio | 0.0613 |
| Current Ratio | 8.340 |
| Net Debt Paydown Yield | -0.09% |